Premier News

New Hires Strengthen Premier Research’s Clinical Development Services, Enhancing Therapeutic and Risk-Based Strategy

MORRISVILLE, N.C., August 15, 2023 — Premier Research has strategically expanded its Clinical Development Services team to enhance therapeutic strategy, special patient population expertise, and risk-based clinical development service offerings for biotech and medtech sponsors. “We pride ourselves on our ability to address the unique and complex needs of every sponsor,” Premier Research Chief Operating...

Premier Research Celebrated at 2023 CRO Leadership Awards

MORRISVILLE, N.C., June 15, 2023 — Premier Research, whose mission is to help the most innovative biotech and medtech companies take their best ideas from concept to commercialization, was honored to be recognized at the 2023 CRO Leadership Awards as a top outsourcing partner. The organization received awards for Compatibility, Expertise, and Reliability in both...

Premier Research Fortifies Cell and Gene Therapy Leadership Team, Strengthening End-to-End Capabilities in Complex Asset Development

Cell and Gene Therapy Expert Dr. Kenneth Ndugga-Kabuye to Lead Clinical Strategy With Collaboration From Operations, CMC and Regulatory Experts MORRISVILLE, N.C., April 17, 2023– Premier Research announced today the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) Leadership Team. Ndugga-Kabuye joins experts...

Premier Research and InSilicoTrials Partner to Leverage In Silico Modeling and Simulation and Optimize Regulatory Pathways for Rare Disease Therapies

MORRISVILLE, N.C., MILAN, ITALY, TRIESTE, ITALY — Premier Research, whose mission is to help the most innovative biotech and device companies take their best ideas from concept to commercialization, and InSilicoTrials, a leader in the use of artificial intelligence (AI) and computational modeling and simulation (CM&S) to accelerate development of new therapies and medical devices, have...

Clinical Research: Phase 1 - Phase 4

Premier Research and CENTOGENE Launch Strategic Partnership to Accelerate and De-Risk Rare Disease Clinical Development

Leveraging Rare Disease Insights Powered by the CENTOGENE Biodatabank and Centralized Multiomic Laboratories in Clinical Trials MORRISVILLE, N.C., and CAMBRIDGE, Mass., ROSTOCK, Germany, and BERLIN, January 9, 2023 — Premier Research, whose mission is to help the most innovative biotech and medtech companies take their best ideas from concept to commercialization, and Centogene N.V. [Nasdaq:...

Clinical Research: Phase 1 - Phase 4

Premier Research Named Partner of Choice

Premier Research has been cited in a Clinical Leader article as the CRO partner of choice for Daré Bioscience. The article, “How To Build A Strong CRO Partnership And Find Drug Development Success,” explores criteria to keep in mind when selecting the ideal CRO partner and how a positive sponsor-CRO partnership led to success in...